CSNK2-IN-2

• UNSPSC Description:

  CSNK2-IN-2 (compound 2) is an orally active CSNK2 inhibitor. CSNK2-IN-2 has an IC50 of 29 μM against CLK11. CSNK2-IN-2 has a half-life of 2.5 h and an AUC of 10,100 h × nM. CSNK2-IN-2 can be used in antiviral studies[1].

• Target Antigen:

  Casein Kinase

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage;Stem Cell/Wnt

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/csnk2-in-2.html

• Smiles:

  CCC(NC1=CC(NC2=NC3=C(C#N)C=NN3C(NC4CC4)=C2)=C(F)C=C1N5C[C@@H](NC)CCC5)=O

• Molecular Weight:

  491.56

• References & Citations:

  [1]Ong HW, et al. Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2. Molecules. 2024 Sep 2;29(17):4158.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported